Skip to main content


Springer Nature is making SARS-CoV-2 and COVID-19 research free. View research | View latest news | Sign up for updates

Table 2 Impact of HER4 expression on the overall survival (OS) and disease-free survival (DFS) in all patients (independent of menopausal status and treatment)

From: HER4 expression in estrogen receptor-positive breast cancer is associated with decreased sensitivity to tamoxifen treatment and reduced overall survival of postmenopausal women

Predictor OS DFS
HR 95% CI p value HR 95% CI p value
HER4 continuous 1.08 0.87 1.35 0.474 1.00 0.80 1.25 0.993
HER4-positive (ref. no HER4 expression) 0.90 0.49 1.66 0.736 0.91 0.54 1.55 0.733
  1. CI confidence interval, HR hazard ratio